NEW PATHWAYS OF CORTICOSTEROID METABOLISM
NEW PATHWAYS OF CORTICOSTEROID METABOLISM
批准号:
3152201
负责人:
CARL MONDER
金额:
$29.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1981
资助国家:
美国
项目状态:
已结题
起止时间:
1981-10-01 至 1990-04-30
关键词:
adrenal hyperplasia carboxylate chromatography corticosteroid analog corticosteroids cortisol electrofocusing gas chromatography mass spectrometry genetic mapping glucocorticoids human subject hydroxylation isomerase liver major histocompatibility complex orphan disease /drug oxidation reduction reaction radioimmunoassay stereochemistry steroid hormone metabolism urinalysis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our goals are to elaborate the details of and evaluate the significance of
new pathways of corticosteroid metabolism. We have shown in all species
studied, including man, that the ketol side chain is reversibly converted
by an isomerase to an aldol configuration that can undergo further
changes. Interconversion of the 20Alpha and 20Beta epimeric forms of the
aldol is catalyzed by an epimerase. Either epimer is oxidized to the
hydroxy acid side chain (cortic acids in man) by aldehyde dehydrogenases or
reduced to glycols (cortols and cortolones in man) by aldo reductase. The
properties of the enzymes that catalyze these changes, isolated from the
livers of hamsters and mice, are being studied in detail in order to
develop a basis for understanding how the various pathways of
corticosteroid metabolism are controlled and coordinated. In parallel
studies in humans, metabolic pathways corresponding to those in animals are
inferred from the urinary metabolites derived from intravenously injected
precursors. The metabolic and clinicophathological significance in man of
the expanded pathways of corticosteroid metabolism are under study. In
humans, we will use methods that we have developed in order to study how a
variety of physiological conditions affect the urinary excretion of the
cortoic acids. We will especiallly study infant and juvenile urine in
order to establish what other steroid acid metabolites are excreted, and to
isolate and identify them. The physiological fractions of the acid
end-products of cortisol metabolism and the aldol intermediates will be
evaluated by standard anti-inflammatory assays and by induction of specific
enzymes such as tyrosines aminotransferase and glycogen synthetase which
are known to respond to glucocorticoids. We will continue our studies of
side chain isomerase genetics in the mouse in order to specifically map the
gene and to establish its multiplicity. Our intentions are to use these
studies as models for possible genetic defects of corticosteroid metabolism
in humans.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Stimulation of mouse liver corticosteroid side chain isomerase by cobaltous and nickelous ions: evidence for an endogenous inhibitor of isomerase activity.
钴离子和镍离子刺激小鼠肝脏皮质类固醇侧链异构酶:异构酶活性内源性抑制剂的证据。
DOI:
10.1016/0003-9861(84)90424-7
发表时间:
1984
期刊:
Archives of biochemistry and biophysics
影响因子:
3.9
作者:
[Iohan,F, Monder,C]
通讯作者:
Monder,C
A comparison of the tissue distribution and metabolism of 11-deoxy-[1,2-3H]corticosterone in the BALB/c and C57BL/6 strains of mice.
BALB/c和C57BL/6品系小鼠中11-脱氧-[1,2-3H]皮质酮的组织分布和代谢比较。
DOI:
10.1210/endo-113-4-1400
发表时间:
1983
期刊:
Endocrinology
影响因子:
4.8
作者:
[Marandici,A, Monder,C]
通讯作者:
Monder,C
Aldose and aldehyde reductase exhibit isocorticosteroid reductase activity.
醛糖和醛还原酶表现出异皮质类固醇还原酶活性。
DOI:
10.1111/j.1432-1033.1983.tb07280.x
发表时间:
1983
期刊:
European journal of biochemistry
影响因子:
--
作者:
[Wermuth,B, Monder,C]
通讯作者:
Monder,C
Synthesis of tritium labeled cortoic acids.
氚标记的皮质酸的合成。
DOI:
10.1016/0022-4731(89)90462-7
发表时间:
1989
期刊:
Journal of steroid biochemistry
影响因子:
--
作者:
[Monder,C, Marandici,A, Iohan,F, Lakshmi,V, Rosen,JE]
通讯作者:
Rosen,JE
The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.
明显盐皮质激素过多综合征:与 11 β-脱氢酶和 5 β-还原酶缺乏相关以及皮质类固醇代谢的一些后果。
DOI:
10.1210/jcem-63-3-550
发表时间:
1986
期刊:
The Journal of clinical endocrinology and metabolism
影响因子:
--
作者:
[Monder,C, Shackleton,CH, Bradlow,HL, New,MI, Stoner,E, Iohan,F, Lakshmi,V]
通讯作者:
Lakshmi,V
共 13 条
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235796
-
项目类别:
-
资助金额:$26.06万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235802
-
项目类别:
-
资助金额:$22.99万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235798
-
项目类别:
-
资助金额:$6.81万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235804
-
项目类别:
-
资助金额:$27.8万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235799
-
项目类别:
-
资助金额:$7.83万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
CORTICOSTERIOD METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235795
-
项目类别:
-
资助金额:$6.86万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235800
-
项目类别:
-
资助金额:$9.1万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235803
-
项目类别:
-
资助金额:$26.58万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
CORTICOSTEROID METABOLISM IN JUVENILE HYPERTENSION
-
批准号:3235801
-
项目类别:
-
资助金额:$23.44万
-
财政年份:1986
-
负责人:CARL MONDER
-
依托单位:
NEW PATHWAYS OF CORTICOSTEROID METABOLISM
-
批准号:3229870
-
项目类别:
-
资助金额:$29.08万
-
财政年份:1981
-
负责人:CARL MONDER
-
依托单位:
NEW PATHWAYS OF CORTICOSTEROID METABOLISM
-
批准号:3229869
-
项目类别:
-
资助金额:$27.57万
-
财政年份:1981
-
负责人:CARL MONDER
-
依托单位:
NEW PATHWAYS OF CORTICOSTEROID METABOLISM
-
批准号:3229872
-
项目类别:
-
资助金额:$31.37万
-
财政年份:1981
-
负责人:CARL MONDER
-
依托单位:
NEW PATHWAYS OF CORTICOSTEROID METABOLISM
-
批准号:3229871
-
项目类别:
-
资助金额:$30.43万
-
财政年份:1981
-
负责人:CARL MONDER
-
依托单位:
海外基金